Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper
2022 · Clinical Cancer Research · 161 citations
https://doi.org/10.1158/1078-0432.ccr-22-0301
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
13
Citations
1
h-index
1
i10-index
Lisa McWilliams is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Field-Flow Fractionation Techniques & Liver Disease Diagnosis and Treatment & Metabolomics and Mass Spectrometry Studies. The author has an h-index of 1, co-authored 2 publications.
https://doi.org/10.1158/1078-0432.ccr-22-0301
https://doi.org/10.1128/jb.02552-14
Click to start Chat